The company won two prizes in a few days and now they are preparing for China-Italy week 2019.
Exosomics was selected among the 6 most attractive innovative Italian companies in the Biotech sector after participating and showcasing in two different National Competitions held in October 2019: the BSSEC China-Italy Best Startup Showcase & Entrepreneurship Event, in Rome, and the Final Italian Healthcare Venture Forum, in Trieste.
Exosomics has been selected to showcase to interested investors in China at the Chinese Final event of BSSEC and in Germany at the European Final event of Tech Tour Contest.
Exosomics CEO Antonio Chiesi says “I am enthusiastic for the achievements reached by the Company and its excellent team in the last two years and happy that such achievements are recognized in such important international events. We are definitely attractive for investors and now closer to the internationalization of our proprietary technology in liquid biopsy and pan-cancer screening “.